5.81
price up icon0.87%   0.05
after-market Handel nachbörslich: 5.81
loading

Savara Inc Aktie (SVRA) Neueste Nachrichten

pulisher
Jan 10, 2026

Savara Inc. Grants Inducement Awards to New Employees with Stock Options & RSUs - MSN

Jan 10, 2026
pulisher
Jan 10, 2026

How big funds are accumulating Savara Inc. (YB4P) stock2025 Price Action Summary & Capital Protection Trade Alerts - ulpravda.ru

Jan 10, 2026
pulisher
Jan 09, 2026

Why Savara Inc. stock is favored by top institutions2025 Stock Rankings & Growth Focused Entry Reports - ulpravda.ru

Jan 09, 2026
pulisher
Jan 09, 2026

Savara Highlights Autoimmune PAP Burden in Updated Presentation - TipRanks

Jan 09, 2026
pulisher
Jan 09, 2026

How Savara Inc. stock compares to growth peers2025 Institutional Moves & AI Optimized Trading Strategy Guides - ulpravda.ru

Jan 09, 2026
pulisher
Jan 09, 2026

The Bull Case For Savara (SVRA) Could Change Following Exclusive MOLBREEVI Distribution Deal With PANTHERx - simplywall.st

Jan 09, 2026
pulisher
Jan 08, 2026

How Savara Inc. stock benefits from global expansionJuly 2025 Movers & Fast Gaining Stock Strategy Reports - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Will Savara Inc. stock outperform growth indexes2025 Market WrapUp & AI Powered Market Trend Analysis - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Will Savara Inc. stock outperform tech sector in 20252025 Price Momentum & Daily Price Action Insights - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

How Savara Inc. (YB4P) stock compares with top peersProduct Launch & Technical Confirmation Alerts - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

PANTHERx® Rare Selected by Savara as the U.S. Exclusive Specialty Pharmacy for MOLBREEVI - PharmiWeb.com

Jan 08, 2026
pulisher
Jan 08, 2026

Savara : Corporate Presentation - MarketScreener

Jan 08, 2026
pulisher
Jan 08, 2026

Can Savara Inc. stock beat market expectations this quarterJuly 2025 Review & Fast Gain Stock Trading Tips - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

PANTHERx® Rare Selected by Savara as the U.S. Exclusive Specialty Pharmacy for MOLBREEVI* - Yahoo Finance Australia

Jan 08, 2026
pulisher
Jan 08, 2026

Will Savara Inc. stock sustain high P E ratiosPortfolio Performance Summary & AI Forecasted Stock Moves - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Will Savara Inc. (YB4P) stock rise with strong economyBuy Signal & Fast Exit Strategy with Risk Control - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Will Savara Inc. stock reach all time highs in 20252025 Market Sentiment & Safe Investment Capital Preservation Plans - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Aug Volume: How Savara Inc stock compares to growth peersRisk Management & Growth Focused Investment Plans - moha.gov.vn

Jan 08, 2026
pulisher
Jan 06, 2026

Will Savara Inc. stock benefit from sector rotation2026 world cup usa national team group stage key players transition play expert forecast insights - ulpravda.ru

Jan 06, 2026
pulisher
Jan 04, 2026

FDA clock restarts: Savara refiles MOLBREEVI for rare lung disease - MSN

Jan 04, 2026
pulisher
Dec 31, 2025

Oppenheimer Assumes Coverage of Savara (SVRA) With an Outperform Rating - MSN

Dec 31, 2025
pulisher
Dec 31, 2025

FDA Clock Restarts: Savara Refiles MOLBREEVI for Rare Lung Disease - MyChesCo

Dec 31, 2025
pulisher
Dec 30, 2025

Savara (NASDAQ:SVRA) Shares Down 5.1%Should You Sell? - MarketBeat

Dec 30, 2025
pulisher
Dec 30, 2025

Savara Inc. (NASDAQ:SVRA) Short Interest Up 33.1% in December - MarketBeat

Dec 30, 2025
pulisher
Dec 29, 2025

Death Cross: Is Savara Inc stock a defensive play in 2025Market Growth Summary & Safe Capital Growth Plans - moha.gov.vn

Dec 29, 2025
pulisher
Dec 28, 2025

Savara Heads to JPMorgan Conference as Investors Watch Rare Lung Drug - MyChesCo

Dec 28, 2025
pulisher
Dec 28, 2025

With 37% Ownership in Savara Inc. (NASDAQ:SVRA), Institutional Investors Have a Lot Riding on the Business - 富途牛牛

Dec 28, 2025
pulisher
Dec 28, 2025

Swedbank AB Takes $1.96 Million Position in Savara Inc. $SVRA - MarketBeat

Dec 28, 2025
pulisher
Dec 28, 2025

Gap Down: Is Savara Inc YB4P stock a buy for dividend portfolios2025 Trade Ideas & AI Based Buy and Sell Signals - moha.gov.vn

Dec 28, 2025
pulisher
Dec 28, 2025

How Savara Inc. stock reacts to Fed rate cutsSector Performance Review & Your Free Entry to Smart Investing Starts Here - bollywoodhelpline.com

Dec 28, 2025
pulisher
Dec 26, 2025

Savara price target raised to $10 from $8 at HC Wainwright - MSN

Dec 26, 2025
pulisher
Dec 26, 2025

Savara Inc. ticks higher amid takeover speculation - MSN

Dec 26, 2025
pulisher
Dec 25, 2025

Market Review: How MTEN stock performs in high volatility marketsMarket Trend Report & Accurate Intraday Trade Tips - moha.gov.vn

Dec 25, 2025
pulisher
Dec 25, 2025

What is HC Wainwright's Forecast for Savara FY2027 Earnings? - MarketBeat

Dec 25, 2025
pulisher
Dec 24, 2025

Savara (SVRA) Stock Price, Quote, News & History - Benzinga

Dec 24, 2025
pulisher
Dec 24, 2025

FY2029 Earnings Estimate for Savara Issued By HC Wainwright - MarketBeat

Dec 24, 2025
pulisher
Dec 24, 2025

SVRA SEC FilingsSavara Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Dec 24, 2025
pulisher
Dec 23, 2025

Savara stock advances as Guggenheim reiterates Buy rating on BLA resubmission By Investing.com - Investing.com South Africa

Dec 23, 2025
pulisher
Dec 23, 2025

Savara (SVRA) Receives Revised Buy Rating from HC Wainwright & C - GuruFocus

Dec 23, 2025
pulisher
Dec 23, 2025

Savara stock price target raised to $10 from $8 at H.C. Wainwright By Investing.com - Investing.com Nigeria

Dec 23, 2025
pulisher
Dec 23, 2025

Savara stock advances as Guggenheim reiterates Buy rating on BLA resubmission - Investing.com Nigeria

Dec 23, 2025
pulisher
Dec 23, 2025

Savara stock price target raised to $10 from $8 at H.C. Wainwright - Investing.com Nigeria

Dec 23, 2025
pulisher
Dec 23, 2025

How Investors May Respond To Savara (SVRA) Joining S&P Biotech Index After Key MOLBREEVI Patent Win - simplywall.st

Dec 23, 2025
$106.87
price up icon 0.90%
$34.26
price up icon 1.87%
$118.64
price up icon 10.48%
$99.85
price up icon 1.01%
biotechnology ONC
$337.89
price up icon 5.47%
$175.97
price up icon 3.35%
Kapitalisierung:     |  Volumen (24h):